RiverFront Investment Group, LLC
Source: SEC Form 13F · as of Mar 2026RiverFront Investment Group, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $76.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$76.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 30,939 | $28.5M |
| JNJJOHNSON & JOHNSON | 44,856 | $11.0M |
| PMPhilip Morris International Inc | 53,230 | $8.8M |
| ABBVAbbVie Inc. | 38,217 | $8.3M |
| MRKMerck & Co., Inc. | 53,994 | $6.5M |
| ABTABBOTT LABORATORIES | 34,433 | $3.5M |
| AMGNAMGEN INC | 6,417 | $2.3M |
| BMYBRISTOL MYERS SQUIBB CO | 32,385 | $2.0M |
| MCKMcKesson Corporation | 1,629 | $1.4M |
| PFEPFIZER INC | 43,534 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,319 | $898K |
| NVSNovartis AG | 3,981 | $608K |
| GILDGILEAD SCIENCES, INC. | 3,589 | $500K |
| CORCencora Inc. | 1,416 | $445K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 929 | $415K |
| AZNASTRAZENECA PLC | 1,726 | $340K |
| ELVElevance Health Inc. | 901 | $264K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.